$MNLO

06.04.20 Secondary Announcement

This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]

Menlo Therapeutics #IPO Preview $MNLO

Company: Menlo Therapeutics, Inc. Symbol: MNLO Description: They are a late‑stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. Shares: 5.67 million Price Range: $14.00-$16.00 Trade Date: 1/25 Underwriter(s): Jefferies, Piper Jaffray, Guggenheim Securities[…]

Scroll to top
error: Content is protected !!